Socioepidemiology of Injection Drug Users in Miami and HIV-1B Envelope (V1–V5) Genetic Diversity: A Preliminary Study

[1]  N. El-Bassel,et al.  Safe havens and rough waters: networks, place, and the navigation of risk among injection drug-using Malaysian fishermen. , 2014, The International journal on drug policy.

[2]  H. Hagan,et al.  The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. , 2014, AIDS education and prevention : official publication of the International Society for AIDS Education.

[3]  J. Kelly,et al.  Using social network methods to reach out-of-care or ART-nonadherent HIV+ injection drug users in Russia: addressing a gap in the treatment cascade , 2014, Journal of the International AIDS Society.

[4]  T. Rhodes,et al.  Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework. , 2013, Drug and alcohol dependence.

[5]  J. Havens,et al.  Network Structure and the Risk for HIV Transmission Among Rural Drug Users , 2013, AIDS and Behavior.

[6]  Peter J. Cistone,et al.  A connectivity model for assessment of HIV transmission risk in injection drug users (IDUs). , 2013, Evaluation and program planning.

[7]  Dennis Maletich Junqueira,et al.  Reviewing the History of HIV-1: Spread of Subtype B in the Americas , 2011, PloS one.

[8]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[9]  Paul Sandstrom,et al.  Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs , 2011, PloS one.

[10]  J. Carr,et al.  Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. , 2009, AIDS research and human retroviruses.

[11]  Richard Rothenberg,et al.  HIV transmission networks , 2009, Current opinion in HIV and AIDS.

[12]  Tulio de Oliveira,et al.  High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania , 2008, PloS one.

[13]  P. Shapshak,et al.  Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. , 2006, AIDS patient care and STDs.

[14]  D. Bryant,et al.  A Simple and Robust Statistical Test for Detecting the Presence of Recombination , 2006, Genetics.

[15]  D. Huson,et al.  Application of phylogenetic networks in evolutionary studies. , 2006, Molecular biology and evolution.

[16]  T. Hahn,et al.  Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission , 2005, Retrovirology.

[17]  L. Metsch,et al.  The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida. , 2004, Memorias do Instituto Oswaldo Cruz.

[18]  M. Nei,et al.  Prospects for inferring very large phylogenies by using the neighbor-joining method. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[20]  J. Margolick,et al.  Influence of Random Genetic Drift on Human Immunodeficiency Virus Type 1 env Evolution During Chronic Infection , 2004, Genetics.

[21]  B. Korber,et al.  HIV sequence compendium 2002 , 2002 .

[22]  V. Moulton,et al.  Neighbor-net: an agglomerative method for the construction of phylogenetic networks. , 2002, Molecular biology and evolution.

[23]  S Kumar,et al.  Disparity index: a simple statistic to measure and test the homogeneity of substitution patterns between molecular sequences. , 2001, Genetics.

[24]  M. Nei,et al.  Molecular Evolution and Phylogenetics , 2000 .

[25]  M Steel,et al.  Invariable sites models and their use in phylogeny reconstruction. , 2000, Systematic biology.

[26]  L. Metsch,et al.  HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. , 2000, Drug and alcohol dependence.

[27]  J. Page,et al.  Use of needles and syringes in Miami and Valencia: observations of high and low availability. , 1999, Medical anthropology quarterly.

[28]  K. Crandall,et al.  Independent evolution of HIV type 1 in different brain regions. , 1999, AIDS research and human retroviruses.

[29]  K. Crandall,et al.  Novel tetrameric tip motifs (APGK and VPGK) in the V3 loop of HIV type 1 envelope sequences in blood and brain from two injection drug users in Miami, Florida. , 1997, AIDS research and human retroviruses.

[30]  L. Metsch,et al.  Injection drug users' practices and attitudes toward intervention and potential for reducing the transmission of HIV. , 1997, Medical anthropology.

[31]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[32]  A. J. Brown,et al.  Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Efron,et al.  Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Bonhoeffer,et al.  HIV-1 Evolution and Disease Progression , 1996, Science.

[35]  B. Efron,et al.  Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. J. Herrera,et al.  The Tat and C2-V3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1. , 1996, Virology.

[37]  K. Bletzer,et al.  Sex, drugs, and the spread of HIV/AIDS in Belle Glade, Florida. , 1996, Medical anthropology quarterly.

[38]  D. Vlahov,et al.  Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[39]  E. Trapido,et al.  Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. , 1995, American journal of public health.

[40]  P. Shapshak,et al.  Highly divergent env sequences of HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient in Miami, Florida. , 1995, AIDS research and human retroviruses.

[41]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[42]  K. Crandall,et al.  Intraspecific phylogenetics: support for dental transmission of human immunodeficiency virus , 1995, Journal of virology.

[43]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[44]  E. G. Shpaer,et al.  Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil , 1994, Journal of virology.

[45]  C. Kuiken,et al.  Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[47]  M. Salminen,et al.  Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. , 1993, Virology.

[48]  E. Holmes,et al.  Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. , 1993, The Journal of infectious diseases.

[49]  M. Nei,et al.  Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. , 1993, Molecular biology and evolution.

[50]  B. Chesebro,et al.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.

[51]  N. Torre,et al.  Wide distribution of two subtypes of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.

[52]  C. Kuiken,et al.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.

[53]  J. Goudsmit,et al.  HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. , 1992, Virology.

[54]  E. Holmes,et al.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Mullins,et al.  Molecular Epidemiology of HIV Transmission in a Dental Practice , 1992, Science.

[56]  M. Weeks,et al.  AIDS and the i.v. drug user: the local context in prevention efforts. , 1992, Medical anthropology.

[57]  I. Onorato,et al.  HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control. , 1992, American journal of public health.

[58]  G. Shaw,et al.  Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo , 1992, Journal of virology.

[59]  A. Dress,et al.  A canonical decomposition theory for metrics on a finite set , 1992 .

[60]  B. Korber,et al.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.

[61]  E. Trapido,et al.  The donation and sale of blood by intravenous drug users. , 1991, American journal of public health.

[62]  H. Gendelman,et al.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Goudsmit,et al.  Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[64]  W. O'brien,et al.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.

[65]  J. Davide,et al.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.

[66]  Reed J. Harris,et al.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.

[67]  J. Page,et al.  Shooting Scenarios and Risk of HIV-1 Infection , 1990 .

[68]  J. Page,et al.  Intravenous Drug Use and HIV Infection in Miami , 1990 .

[69]  F. Tajima.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. , 1989, Genetics.

[70]  J. Berzofsky,et al.  A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. , 1989, Science.

[71]  A J Langlois,et al.  Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Page,et al.  Shooting Galleries, Their Proprietors, and Implications for Prevention of AIDS , 1989 .

[73]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[74]  G. Shaw,et al.  Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions , 1987, Journal of virology.

[75]  N. Monplaisir,et al.  NEEDLESTICK HIV SEROCONVERSION IN A NURSE , 1986, The Lancet.

[76]  É. Oksenhendler,et al.  HIV infection with seroconversion after a superficial needlestick injury to the finger. , 1986, The New England journal of medicine.

[77]  Stricof Rl,et al.  HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury. , 1986 .

[78]  D. Drutz.  Antigen detection in fungal infections. , 1986, The New England journal of medicine.

[79]  M. Nei,et al.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.

[80]  M. Hirsch,et al.  Primary human T-lymphotropic virus type III infection. , 1985, Annals of internal medicine.

[81]  J. Levy,et al.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. , 1985, The Journal of infectious diseases.

[82]  J. Goedert,et al.  Epidemiological evidence that HTLV-III is the aids agent , 1985, European Journal of Epidemiology.

[83]  F. Brun-Vézinet,et al.  Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. , 1985, JAMA.

[84]  J. Chermann,et al.  Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. , 1984, Science.

[85]  Cantab Ma.  John Crighton Bramwell. , 1976 .

[86]  Claude E. Shannon,et al.  The mathematical theory of communication , 1950 .

[87]  P. Shapshak,et al.  Global Protein Sequence Variation in HIV-1-B Isolates Derived from Human Blood and Brain , 2015 .

[88]  Allen G. Rodrigo,et al.  Computational and Evolutionary Analysis of HIV Molecular Sequences , 2001, Springer US.

[89]  L. Metsch,et al.  Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[90]  C. Luo,et al.  Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. , 1998, The Journal of infectious diseases.

[91]  C. Mccoy,et al.  Skills for HIV risk reduction: evaluation of recall and performance in injecting drug users. , 1997, Substance use & misuse.

[92]  L. Metsch,et al.  HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. , 1995, Archivum immunologiae et therapiae experimentalis.

[93]  J. Goudsmit,et al.  Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination. , 1993, Chemical Immunology.